Delivery Order SPE2DE24D0021-SPE2D626F6K2S

<p>The Department of Defense Medical Supply Chain issued a $5,655.35 delivery order to Fisher Scientific Company L.L.C. on April 17, 2026, for reagent toxicology CEDIA buprenorphine supplies under fixed-price contract terms with economic price adjustment.</p> <p>Place of performance is Pittsburgh, PA 15275. The order ultimate completion date is April 24, 2026. No set-aside applied to this delivery order.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a delivery order to Fisher Scientific Company L.L.C. on April 17, 2026, with a ceiling value of $7,809.53 for reagent toxicology CEDIA buprenorphine testing supplies. Place of performance is Pittsburgh, PA. The order is fixed-price with economic price adjustment and has an ultimate completion date of April 24, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a $1,322.20 delivery order to Amerisourcebergen Drug Corp on February 25, 2026, for Buprenorphine 0.3 mg/mL vials.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 26, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a $1,078 delivery order to Fisher Scientific Company L.L.C. on April 27, 2026, for medical supplies with a fixed-price-with-economic-price-adjustment structure.</p> <p>Place of performance is Pittsburgh, PA. The order has an ultimate completion date of May 8, 2026. This delivery order was issued under no set-aside.</p>

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Buprenorphine 0.3 mg/mL vials valued at $1,058.70. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by July 30, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is a child contract under AmerisourceBergen's substantial...

<p>The Department of Defense Medical Supply Chain issued a $1,135.77 delivery order to Fisher Scientific Company L.L.C. on March 19, 2026, with an ultimate completion date of March 26, 2026.</p> <p>The order is issued under a Blanket Purchase Agreement (BPA) parent vehicle. Place of performance is Pittsburgh, PA. The order carries fixed-price pricing with economic price adjustment and no set-aside designation.</p>

<p>The Defense Department's Medical Supply Chain issued a $15,953.90 delivery order to Fisher Scientific Company L.L.C. on March 3, 2026, for CEDIA heroin metabolite (6-acetylmorphine) assay kits in 65 mL format, with completion targeted for March 10, 2026.</p> <p>Place of performance is Pittsburgh, PA. The order is priced on a fixed-price basis with economic price adjustment. No set-aside was applied.</p>

<p>The Department of Defense Medical Supply Chain issued a $1,940.82 delivery order to Fisher Scientific Company L.L.C. on April 13, 2026, with an ultimate completion date of April 16, 2026.</p> <p>Place of performance is Pittsburgh, PA. The order is priced on a fixed-price basis with economic price adjustment. No set-aside was used.</p>

<p>The Department of Defense Medical Supply Chain issued a $1,184.88 delivery order to Fisher Scientific Company L.L.C. on May 12, 2026, for medical supplies with an ultimate completion date of May 19, 2026.</p> <p>Place of performance is Pittsburgh, PA. The order is priced fixed-price with economic price adjustment and carries no set-aside designation.</p>

<p>The Department of Defense Medical Supply Chain issued a $2,426.16 delivery order to Fisher Scientific Company L.L.C. on March 9, 2026, for BHB bi-level control material (6x5mL/pack).</p> <p>Place of performance is Pittsburgh, PA 15275. Ultimate completion date is March 12, 2026. Pricing is fixed price with economic price adjustment. No set-aside was used.</p>